See All Slides - tctmd.com

Slides

Presentation AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Presenter: Weon Kim

November 04, 2012

Presentation AHA 2012

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

Presenter: Eric L. Eisenstein

November 04, 2012

Presentation AHA 2012

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Presenter: Paul A. Gurbel

November 04, 2012

Presentation AHA 2012

FREEDOM Trial Main Results

Presenter: Valentin Fuster

November 04, 2012

Presentation TCT 2012

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Presenter: Bruce Bowers

October 26, 2012

Presentation TCT 2012

Introduction to the TAVR Procedure

Presenter: Martyn Thomas

October 26, 2012

Presentation TCT 2012

PC Trial: Additional Findings

Presenter: Stephan Windecker

October 26, 2012

Presentation TCT 2012

Risk-Standardized 30-Day Mortality Rates: What Are They and How Do We Improve Them?

Presenter: Henry Ting

October 26, 2012

Presentation TCT 2012

“Tips n' Tricks” for a Facilitated Early Discharge Plan After TAVR Procedures

Presenter: David Wood

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

Advertisement

Slides

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

FREEDOM Trial Main Results

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Introduction to the TAVR Procedure

PC Trial: Additional Findings

Risk-Standardized 30-Day Mortality Rates: What Are They and How Do We Improve Them?

“Tips n' Tricks” for a Facilitated Early Discharge Plan After TAVR Procedures

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content